Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
NCT00574327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2023-03-16
Summary
The purpose of this study is to determine or evaluate the risk factors such as smoking, family history etc. that cause esophageal cancer and to determine the genetic changes that lead to esophageal cancer. The investigators hypothesis is that systematic collection of data on the natural history of GERD and BE patients and risk factors for development of BE in patients with chronic GERD and progression of BE to dysplasia and adenocarcinoma will provide useful information to develop a decision model for risk stratification and risk reduction strategies in these patients.
As of March 17, 2011, 585 patients have consented at the Kansas City VA Medical Center.
Conditions
- Barrett's Esophagus
- Gastroesophageal Reflux Disease
- Esophageal Adenocarcinoma
Sponsors & Collaborators
-
Kansas City Veteran Affairs Medical Center
collaborator FED -
Midwest Biomedical Research Foundation
lead OTHER
Principal Investigators
-
Prateek Sharma, MD · Department of Veterans Affairs Medical Center of Kansas City
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2028-10-31
- Completion
- 2029-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT06523374 ·Status: RECRUITING ·Phase: NA
-
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
NCT01568723 ·Status: COMPLETED
-
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
NCT05688176 ·Status: RECRUITING
-
Racial Disparity in Barrett's Esophagus
NCT01374074 ·Status: COMPLETED
-
The Microenvironment in Barrett's Esophagus
NCT03060642 ·Status: COMPLETED
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905 ·Status: COMPLETED
-
Early Detection of Barrett's Esophagus
NCT00081354 ·Status: COMPLETED
-
Molecular Assessment for Gastro-Esophageal Cancer
NCT06346054 ·Status: RECRUITING ·Phase: NA
-
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
NCT05524844 ·Status: COMPLETED
-
Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 ·Status: COMPLETED
-
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Ablation Therapy on Barrett's Esophagus
NCT00587314 ·Status: ENROLLING_BY_INVITATION
-
Erlotinib in Treating Patients With Barrett Esophagus
NCT00566800 ·Status: UNKNOWN ·Phase: PHASE1
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT03961945 ·Status: RECRUITING ·Phase: NA
-
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
NCT07212491 ·Status: ENROLLING_BY_INVITATION
-
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
NCT00619242 ·Status: TERMINATED ·Phase: NA
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Enhancing Screening Practices for BE
NCT07335445 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
NCT00844077 ·Status: COMPLETED
-
University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
NCT02427269 ·Status: ENROLLING_BY_INVITATION
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
NCT01961778 ·Status: COMPLETED ·Phase: NA
-
Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
NCT00570531 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
NCT06693622 ·Status: RECRUITING
-
Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus
NCT01572987 ·Status: TERMINATED ·Phase: NA
-
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623 ·Status: COMPLETED ·Phase: NA